Haemonetics Corp’s recent filing unveils that its Former Officer Lingamneni Anila acquired Company’s shares for reported $0.57 million on Nov 11 ’24. In the deal valued at $90.68 per share,6,238 shares were bought.
Then, Strong Stewart W sold 4,312 shares, generating $393,039 in total proceeds. Upon selling the shares at $91.15, the President, Global Hospital now owns 18,196 shares.
Before that, Strong Stewart W bought 4,312 shares. Haemonetics Corp shares valued at $393,039 were divested by the Officer at a price of $91.15 per share.
BofA Securities downgraded its Haemonetics Corp [HAE] rating to an Underperform from a a Neutral in a research note published on February 07, 2025; the price target was decreased to $68 from $95. A number of analysts have revised their coverage, including JP Morgan’s analysts, who began to cover the stock in early December with a ‘”an Overweight”‘ rating. Raymond James also remained covering HAE and has increased its forecast on November 08, 2024 with a “Strong buy” recommendation from previously “an Outperform” rating. CL King started covering the stock on September 13, 2024. It rated HAE as “a Buy”.
Price Performance Review of HAE
On Tuesday, Haemonetics Corp [NYSE:HAE] saw its stock jump 2.12% to $63.97. Over the last five days, the stock has gained 8.15%. Haemonetics Corp shares have fallen nearly -18.07% since the year began. Nevertheless, the stocks have fallen -27.02% over the past one year. While a 52-week high of $97.97 was reached on 01/15/25, a 52-week low of $55.30 was recorded on 04/09/25. SMA at 50 days reached $63.17, while 200 days put it at $74.58.
Levels Of Support And Resistance For HAE Stock
The 24-hour chart illustrates a support level at 62.62, which if violated will result in even more drops to 61.27. On the upside, there is a resistance level at 64.78. A further resistance level may holdings at 65.59. The Relative Strength Index (RSI) on the 14-day chart is 58.26, which indicates neutral technical sentiment, while the Moving Average Convergence Divergence (MACD) stands at 3.07, which suggests price will go up in the next trading period. Percent R suggests that price movement has been bullish at 3.02%. Stochastics %K at 95.30% indicates the stock is a selling.
How much short interest is there in Haemonetics Corp?
A steep rise in short interest was recorded in Haemonetics Corp stocks on 2025-04-15, dropping by -1.6 million shares to a total of 4.43 million shares. Yahoo Finance data shows the prior-month short interest on 2025-03-14 was 6.03 million shares. There was a decline of -36.02%, which implies that there is a negative sentiment for the stock.
The most recent change occurred on September 11, 2024 when BofA Securities began covering the stock and recommended ‘”a Neutral”‘ rating along with a $85 price target.
